Innovating Works

FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON

Inactiva
Penphomet: PEN photoporation for the genetic engineering of therapeutic mesenchymal stromal cells and T cells TRINCE tramitó un HORIZON EUROPE: HORIZON-EIC-2023-TRANSITION-01 Adoptive cell therapy has emerged as a promising strategy to treat cancer. It relies on patient-derived cells, such as T cells and mesenchym...
2024-02-26 - 2027-02-28 | Financiado
COMBINE-CT: Combining CT diagnostic data and interventional approaches for futureproof cardiology care PHILIPS MEDICAL SYSTEMS NEDERLAND BV tramitó un HORIZON EUROPE: HORIZON-JU-IHI-2022-03-single-stage "Coronary artery disease (CAD) is caused by the pathological process in which fat, cholesterol and calcium accumulate on the arterial wall....
2023-10-27 - 2027-10-31 | Financiado
RESILIENCE: Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines. CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un H2020: H2020-SC1-BHC-2018-2020 The increasing life expectancy of the population and the development of effective therapies result in a growing population of aged cancer su...
2021-01-29 - 2026-05-31 | Financiado
HARMONY PLUS: HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY PLUS FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON tramitó un H2020: H2020-JTI-IMI2-2019-19-single-stage Haematological malignancies (HM), also known as blood cancers, are a heterogeneous and complex group of multicausal diseases that can’t be e...
2020-05-26 - 2024-03-31 | Financiado
oncNGS: NGS diagnostics in 21st century oncology the best for all at all times SCIENSANO tramitó un H2020: H2020-SC1-BHC-2018-2020 OncNGS consortium challenges the market to research and develop novel affordable solutions to provide the best NGS tests, for all solid tumo...
2019-12-13 - 2026-04-30 | Financiado
HERMES: Hybrid Enhanced Regenerative Medicine Systems FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA tramitó un H2020: H2020-FETPROACT-2018-2020 Brain disorders are the most invalidating condition, exceeding HIV, cancer and heart ischemia, with significant impact on society and public...
2018-11-12 - 2024-12-31 | Financiado
HARMONY: Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY Sofia ref.... FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON tramitó un H2020: H2020-JTI-IMI2-2015-06-two-stage Despite significant recent progress in the field of hematological malignancies (HMs), with increasing survival rates and improvement in qual...
2016-12-22 - 2023-06-30 | Financiado
PANA: PROMOTING ACTIVE AGEING FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER S DISEASE AT ULTRA EARLY STAGES. SERVICIO GALEGO DE SAUDE SERGAS tramitó un H2020: H2020-NMP-2014-2015 Alzheimer’s disease (AD) is the leading cause of dementia and loss of autonomy in the elderly, implying a progressive cognitive decline and...
2016-03-04 - 2021-08-31 | Financiado
RESSTORE: REgenerative Stem cell therapy for STroke in Europe UNIVERSITE GRENOBLE ALPES tramitó un H2020: H2020-PHC-2014-2015 Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, due to motor and co...
2015-09-15 - 2020-08-31 | Financiado
MDS-RIGHT: Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time STICHTING RADBOUD UNIVERSITEIT tramitó un H2020: H2020-PHC-2014-2015 Myelodysplastic syndromes (MDS) are chronic bone marrow malignancies of the elderly, complicated by severe anaemia. MDS significantly affect...
2015-04-07 - 2020-10-31 | Financiado
RETHRIM: Restoring tissue regeneration in patients with visceral Graft versus Host Disease. ACADEMISCH ZIEKENHUIS LEIDEN tramitó un H2020: H2020-PHC-2014-2015 Stem cell regenerative therapies hold great promise for patients suffering from a variety of disorders that are associated with tissue or or...
2014-12-01 - 2021-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.